Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study is a prospective, randomized phase II clinical trial, to compare the efficacy and
safety profiles of standard chemotherapy versus standard chemotherapy followed by
capecitabine as prolonged postoperative adjuvant treatment for breast cancer patients.